Episode 52
Trust, Teamwork, and Innovation, with Natalie Nairn, Co-founder and CEO of Cyclera Therapeutics
This week, I spoke with Natalie Nairn, co-founder and CEO of Cyclera Therapeutics. Natalie is also a Termeer Fellow, and listeners of this podcast know how much I love the Termeer Foundation. We discuss her transition from chemical engineering to biomedical applications. She describes her unexpected path into the fun and volatile startup space, which led to her founding Cyclera. Natalie explains the importance of focusing in biotech development, the promising applications of Cyclera's technology in CNS therapeutics, and the challenges and opportunities in the current funding landscape. She also highlights the value of the Termeer fellowship in her career, the contrast between Boston and Seattle's biotech scenes, and the essential aspects of leadership and team cohesion. Finally, Natalie discusses her future goals for Cyclera and offers valuable advice for aspiring biotech founders.
- Get Natalie's recommended book! The Book of Delights: Essays
- CYpHER: catalytic extracellular targeted protein degradation with high potency and durable effect | Nature Communications
- Connect with Natalie on LinkedIn!
- Learn more about Cyclera Therapeutics
Connect with us!
Subscribe here:
Learn more about Recruitomics Consulting
Check out our reading list
Download our free startup resources guide to grow your biotech efficiently
If you're on the job market, visit the Collaboratory Career Hub
00:00 Introduction and Early Aspirations
00:33 Journey into Biomedical Engineering
01:19 First Startup Experience
03:40 Founding Cyclera
05:02 Focus on CNS Therapeutics
13:35 Challenges and Strategies in Biotech
15:39 The Termeer Foundation Fellowship
21:26 Biotech Networks: Boston vs. Seattle
26:50 Future of Cyclera and Personalized Medicine
32:45 Conclusion and Final Thoughts
